SUMITOMO PHARMA CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 332 JPY | -4.87% |
|
+16.49% | -28.76% |
| May. 14 | Transcript : Sumitomo Pharma Co., Ltd., 2024 Earnings Call, May 14, 2024 | |
| May. 14 | Sumitomo Pharma Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024 | CI |
ETFs positioned on Sumitomo Pharma Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.38% | 19 M€ | +13.48% | ||
| 0.15% | 64,792 M€ | +16.73% | ||
| 0.13% | 28,258 M€ | +16.69% | - | |
| 0.11% | 1,083 M€ | +5.03% | ||
| 0.10% | 15,324 M€ | +15.74% | - | |
| 0.06% | 4 M€ | +20.72% | ||
| 0.06% | 57 M€ | +19.45% | ||
| 0.05% | 14 M€ | +19.96% | ||
| 0.05% | 70 M€ | +17.81% | ||
| 0.03% | 4,929 M€ | +17.97% | ||
| 0.03% | 9,760 M€ | +18.09% | ||
| 0.03% | 17 M€ | +16.94% | - | |
| 0.02% | 20,360 M€ | +16.62% | - | |
| 0.02% | 63,295 M€ | +17.80% | - | |
| 0.02% | 140,441 M€ | +17.76% | ||
| 0.01% | 746 M€ | -.--% | - | |
| 0.01% | 7 M€ | +6.05% | - | |
| 0.00% | 32 M€ | +7.35% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +9.03% | - | |
| 0.00% | 391 M€ | +9.65% | - | |
| 0.00% | 39 M€ | +6.40% | - | |
| 0.00% | 306 M€ | +6.45% | - | |
| 0.00% | 34 M€ | +4.11% | - |
Sumitomo Pharma Co., Ltd. (formerly Sumitomo Dainippon Pharma Co., Ltd.) specializes in development, manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceuticals (92.9%): for cardiovascular, gastrointestinal and infectious diseases, central nervous systems disorders and allergies treatment;
- other (7.1%): veterinary drugs, food additives, industrial chemical products, etc.
Net sales are distributed geographically as follows: Japan (39.8%), the United States (50.4%), North America (0.9%) and other (8.9%).
Sector
Pharmaceuticals
Calendar
2024-07-28
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
332
JPY
Average target price
326.2
JPY
Spread / Average Target
-1.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -28.76% | 888M | |
| +43.41% | 749B | |
| +39.42% | 605B | |
| -6.59% | 351B | |
| +18.89% | 328B | |
| +8.26% | 292B | |
| +11.92% | 216B | |
| -2.62% | 214B | |
| +0.31% | 167B | |
| +5.69% | 165B |
- Stock Market
- Equities
- 4506 Stock
- Funds and ETFs Sumitomo Pharma Co., Ltd.
